Dr. Abou-Khamis completed his
fellowship in Rheumatology at the University of Maryland Medical
System. He has numerous publications, abstracts, and research
presentations to his credit, as well as a variety of professional
awards and honors. He has presented at several national and
international meetings and symposia.
For the past two years, he has been
practicing Internal Medicine and Rheumatology in Baltimore,
Maryland and he recently moved to Houston and joined Hillcroft
Medical Clinic. In his practice, he treats all kinds of arthritis
from non inflammatory type like osteoarthritis and Fibromyalgia to
more complex inflammatory diseases like rheumatoid arthritis,
lupus, systemic sclerosis, vasculitis, sjogren’s syndrome
and others. He is also experienced in infusion therapy and the
practice has an on-site infusion suite that provides patients with
access to such therapy if needed. He is fluent in both English and
Arabic.
- University of Maryland, Baltimore, Maryland
(Fellowship, Rheumatology)
- Good Samaritan Hospital, Baltimore, Maryland
(Residency)
- Baylor College of Medicine, Houston, Texas (Research
Fellow)
- American University of Beirut, (MD)
- American University of Beirut, (B.S. Chemistry)
Experience
- Houston Institute for Clinical Research, Houston,
Texas
- Private Practice of Rheumatology, Houston, Texas
Hospital Affiliations
- Memorial Hermann Southwest Hospital
- Memorial Hermann Sugar Land Hospital
- West Houston Medical Center
- Methodist Sugar Land Hospital
Board Certifications
- American Board of Internal Medicine
- American Board of Rheumatology
Honors & Awards
- Best Graduating Resident Award
- Best Teaching Resident Award
- Best Graduating Fellow Award
- Internal Medicine Chief Resident
- Co-Chair, Chief Resident Association of Baltimore
- Planning Committee for the MedStar Chief Residents
Retreat
- Graduate Medical Education Committee at Good
Samaritan Hospital
- Residency Advisory Committee
- Medical Resident Society
Publications
- Tamim H, Terro A, Kassem H, Ghazi A, Abou-Khamis T,
Abdul Hay M, Musharrafieh U. Tabacco use by university
students, Lebanon, 2001. Addiction.
2003;98(7):933-9.
- Musharrafieh U, Rahi A, Kassem H, Abou-Khamis T,
Abdul Hay M, Hourani R, Ghazi A, Tamim H. Physical activity
among university students in Lebanon. Aust N Z J
Public Health.
- Dewald O, Zymek P, Winkelmann K, Koerting A, Ren G,
Abou-Khamis T, Michael LH, Rollins BJ, Entman ML,
Frangogiannis NG. CCL2/Monocyte chemoattractant Protein-1
regulates inflammatory responses critical to healing
myocardial infarcts. Circ Res. 2005;96(8):881-9.
Epub 2005 Mar 17.
- Huebener P, Abou-Khamis T, Zymek P, Bujak M, Ying X,
Chatila K, Haudek S, Thakker G, Frangogiannis NG. CD44 is
critically involved in infarct healing by regulating the
inflammatory and fibrotic response. J Immunol.
2008;180(4):2625-33.
Book Chapters
- Gallego E, Abou-Khamis T, Flores R.
Rheumatology. In: Wolfsthal SD, editor. National Medical
Series – Medicine. 7th Edition. Lippincott,
Williams and Wilkens, Baltimore, MD. In press for 2010-2011.
Abstracts
- C-C Chemokines in Healing Myocardial Infarcts.
Studies Using MCP-1/CCL2-/-and MIP-1α/CCL3 -/- Mice.
FASEB Meeting, San Diego 2005.
- Abou-Khamis T, Dewald O, Zymek P, Leucker T, Ren G,
Rollins BJ*, Entman ML, and Frangogiannis NG.
- Baylor College of Medicine, Houston, Texas. *Harvard
Medical School, Boston, Massachusetts.
- Monocyte Chemoattractant Protein (MCP)-1/CCL2
Critically Regulates Infarct Healing. ESCI Meeting. Athens,
Greece, 2005.
- Dewald O*, Zymek P*, Abou-Khamis T*, Leucker T*,
Rollins BJ#, Entman ML*, Frangogiannis NG*.
- *Baylor College of Medicine, Houston, Texas. #Harvard
Medical School, Boston, Massachusetts.
- High Dose Cyclophosphamide vs. Traditional Regimen in
Lupus Nephritis. American College of Rheumatology meeting
2007.
- Abou-Khamis T, Magder L, Jones R, Brodsky R, Petri M.
- Oral Presentation: Tabacco Use by University
Students, Lebanon 2001.
- Musharrafieh U, Terro A, Kassem H, Abou-Khamis T,
Tamim H.
- Abstract Presentation: Tricuspid Endocarditis. A Big
Lung Abscess.
- American College of Physicians, Maryland Chapter
meeting. 2005. Abou-Khamis T, Khanna G.
Residency/Fellowship Program Presentations
- Heart Diseases in Lupus. Rheumatology Grand
Rounds.
- Juvenile Onset RA. Rheumatology Grand Rounds.
- Wegeners Granulomatosis. Case presentation.
Rheumatology Grand Rounds.
- Trigeminal Neuralgia. Topic Overview. Teaching
Rounds.
- HIV prophylaxis. Topic Overview. Teaching
Rounds.
- Hypertrophic Cardiomyopathy. Topic Overview. Teaching
Rounds.
- Gatifloxacin Therapy and the Risk Dysglycemia in
Older Patients. Teaching Rounds.
- Current Concepts: Community Acquired Bacterial
meningitis. Teaching Rounds.
- Pneumomediastinum: Chariman Rounds.
- Peripartum Cardiomyopathy. Chairman Rounds.
- Systemic Lupus Erythematosus Overview of Pathogenesis
and Current Treatments. Union Memorial Hospital Grand Rounds.
- Large and Medium Vessel Vasculitis Overview and
Management. Union Memorial Hospital Grand Rounds.
- Scleroderma. Union Memorial Hospital Grand Rounds
- Ideopathic Inflammatory Myopathies. Union Memorial
Hospital Grand Rounds
- Short-Term Corticosteroids Then Lamivudine and Plasma
Exchange to Treat Hepatitis B Virus Related Polyarteritis
Nodosa, Grand Rounds. University of Maryland.
- Herpes Simplex Virus Infections of the CNS:
Encephalitis and Meningitis including Mollaret's. Grand
Rounds. University of Maryland.
- Sarcoid Myopathy. Grand Rounds. University of
Maryland.
- Interferon Gamma Assay for Detection of M.
Tuberculosis Infection. Journal Club. University of Maryland.
- Primary Amyloidosis. Grand Rounds. University of
Maryland.
- The Varicella Zoster Virus Vasculopathis. Grand
Rounds. University of Maryland.
- Lupus and the CNS. Review. Grand Rounds. University
of Maryland.
- Daily Needle Aspirations vs. Surgical Lavage for the
Treatment of Bacterial Septic Arthritis in Adults. Grand
Rounds. University of Maryland.
- Arthritis Associated with IBD. Grand Rounds.
University of Maryland
- MMF vs. Cyclophosphamide for Lupus Nephritis. Journal
Club. University of Maryland.
- Catastrophic Antiphospholipid Syndrome. Grand Rounds.
University of Maryland
- Focal Eosinophilic Myositis. Grand Rounds. University
of Maryland.
- PRECISION TRIAL. Journal Club. University of
Maryland.
- Exfoliative Dermatitis Overview. Grand Rounds.
University of Maryland.
- Pregnancy Outcome in Idiopathic Inflammatory
Myopathy. Grand Rounds. University of Maryland.
- Experience with Rituximan in Scleroderma: Results
From a One Year, Proof-of-Principle Study. Journal Club.
University of Maryland.
- HORIZON TRIAL. Journal Club. University of
Maryland.
Residency Research
- Implementation of An Integrated Multicenter Approach
to Increase Perioperative Beta Blocker Use in Eligible
Patients Undergoing Total Hip and Knee Arthroplasty
(Multicenter Quality Improvement Project)
- High Dose Cyclophosphamide vs. Traditional NIH
Regimen for Severe Lupus Nephritis – presented at the
American College of Rheumatology
Research Protocols
- A Multicenter, Randomized, Double-Blind,
Placebo-Controlled, Parallel Group Study of CNTO 136
(sirukumab), a Human Anti-IL-6 Monoclonal Antibody,
Administered Subcutaneously, in Subjects with Active
Rheumatoid Arthritis Despite Anti-TNFα Therapy.
Protocol CNTO136ARA3003.
- A Multicenter, Open-Label, Long-Term Extension Study
of WA22762 and NA25220 to Evaluate Safety and Efficacy of
Subcutaneous Tocilizumab in Patients with Moderate to Severe
Rheumatoid Arthritis. Protocol ML28338
- Sub-Study Protocol in CNTO136ARA3004: A Multicenter,
Parallel-Group Study of Long-Term Safety and Efficacy of CNTO
136 (sirukumab) for Rheumatoid Arthritis in Subjects
Completing Treatment in Studies CNTO136ARA3002 (SIRROUND-D)
and CNTO136ARA3003 (SIRROUND-T). Protocol CNTO136ARA3004.
- A Multicenter, Parallel-Group Study of Long-Term
Safety and Efficacy of CNTO 136 (sirukumab) for Rheumatoid
Arthritis in Subjects Completing Treatment in Studies
CNTO136ARA3002 (SIRROUND-D) and CNTO136ARA3003 (SIRROUND-T).
Protocol CNTO136ARA3004.
- A Randomized, Double-Blind Trial Assessing the Impact
of Methotrexate Discontinuation on the Efficacy of
Subcutaneous Tocilizumab with Methotrexate Therapy. Protocol
ML28776.